Cdx1 and Cdx2 function as tumor suppressors.

Area of Science:

• Gastroenterology
• Oncology
• Molecular Biology

Background:

• Colorectal cancer (CRC) initiation involves APC loss-of-function, leading to uncontrolled Wnt signaling, crypt hyperplasia, and polyposis.
• CRC is a major global cancer-related death cause, yet initiation, transformation, and invasion processes remain incompletely understood.
• Murine APC(Min/+) models develop nonmetastatic intestinal tumors, limiting their representativeness of human CRC.

Purpose of the Study:

• To investigate the role of Cdx2 and Cdx1 transcription factors in APC(Min/+)-induced colorectal tumorigenesis.
• To develop a more accurate murine model for human colorectal cancer, including invasive phenotypes.

Main Methods:

• Somatic loss of Cdx2, alone or with Cdx1, was assessed in APC(Min/+) mice.
• Tumorigenesis and invasive phenotypes were analyzed in the adult gastrointestinal tract.

Main Results:

• APC(Min/+)-Cdx2 mutants exhibited polyposis and recapitulated key aspects of human CRC, including invasiveness.
• Concomitant loss of Cdx1 in APC(Min/+)-Cdx2 mice significantly increased distal colon tumor incidence.
• These findings highlight previously unrecognized roles for Cdx1 and Cdx2 in intestinal tumorigenesis.

Conclusions:

• Cdx2 loss collaborates with APC mutations to promote invasive colorectal cancer phenotypes in a murine model.
• Cdx1 acts as a tumor suppressor in the distal colon, and its loss exacerbates APC-driven tumorigenesis.
• Cdx family members play critical, previously unrecognized roles in the initiation and progression of intestinal tumors.